Drug recall · April 13, 2022
Janumet recall
Why: Presence of foreign substance: Presence of stainless steel particulates in tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)
- Lots / codes
Lot: U015824, Exp. 09/22.
- Quantity
- 3600 cartons
- Company
- Merck Sharp & Dohme Corp, Whitehouse Station, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 31, 2022 · Voluntary: Firm initiated
- Classified
- April 5, 2022
- Reported
- April 13, 2022
- Ended
- August 15, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Janumet
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.